Baudax Bio Inc (BXRXQ)

[SuperDrive]

For comparison: $PCRX who's bread-winner is EXPAREL, a non-opioid medication administered at the time of surgery to control pain while reducing opioid requirements, has revenues of about $400M. It trades at 4 times revenue.

If as analysts predicts, $BXRX reaches peak revenue of $350M, if you apply an even lower multiple, say 2.5, you'd get to a $875M market cap.
If fully diluted we end up with 25M shares --> you'd get at a share price of: 35$ !!!!!!

If Peak sales are overestimated and we just get half of it, PPS should still be, if you follow $PCRX metric at: $17!!!!

THAT IS A 630% GAIN FROM TODAY'S PRICE ($2.7)!!!!!!!!!!!!!!!